Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China flag China · Delayed Price · Currency is CNY
31.91
-0.27 (-0.84%)
Aug 31, 2026, 3:04 PM CST

SHE:002294 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
935.3968.431,1251,3222,6703,236
Short-Term Investments
824.041,433988.85695.51531.58-
Trading Asset Securities
548.85688.98733.86186.06328.3660
Cash & Short-Term Investments
2,3083,0912,8482,2043,5303,296
Cash Growth
-20.23%8.52%29.25%-37.58%7.12%205.25%
Accounts Receivable
928.72850.55565.87545.38557.72474.03
Other Receivables
23.9830.8723.8521.0123.4155.48
Receivables
952.7881.42589.72566.39581.12629.51
Inventory
567.72548.19506.76490.86543.53420.45
Other Current Assets
95.962.5380.0252.4356.3658
Total Current Assets
3,9254,5834,0253,3134,7114,404
Property, Plant & Equipment
1,5631,5321,4301,4571,5061,638
Long-Term Investments
1,378907.011,4921,701963.07854.48
Goodwill
219.49219.4910.9110.9160.5387.14
Other Intangible Assets
1,4021,4111,3351,318965.461,048
Long-Term Deferred Tax Assets
251.98215.64151.2487.488.4282.01
Long-Term Deferred Charges
2,2121,9961,5971,4161,3441,047
Other Long-Term Assets
123.85433.8424.7793.31116.6483.09
Total Assets
11,07511,29810,4669,3979,7559,244

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
174.09184.79126.09156.01219.65187.67
Accrued Expenses
918.96906.58716.68491.34558.35487.02
Short-Term Debt
155.18263.3412040177.1963
Current Portion of Leases
7.135.869.710.9311.466.99
Current Income Taxes Payable
12.9425.967.1510.4928.9237.2
Current Unearned Revenue
46.5248.9439.3529.5542.6697.99
Other Current Liabilities
621.43578.569476.77565.4132.98
Total Current Liabilities
1,9362,0141,113815.081,6041,013
Long-Term Debt
246.84-----
Long-Term Leases
19.0920.984.1812.5419.589.11
Long-Term Unearned Revenue
151.22149.12142.0484.1198.5393.71
Long-Term Deferred Tax Liabilities
30.3732.1620.9713.0427.18-
Other Long-Term Liabilities
-27.54433.14416.4729.6482.57
Total Liabilities
2,3842,2441,7131,3411,7791,198

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
1,1151,1151,1151,1151,1151,115
Additional Paid-In Capital
2,0802,0811,9281,9001,8661,930
Retained Earnings
5,4945,7205,6205,5645,5295,330
Treasury Stock
-113.69---602.16-602.16-327.86
Comprehensive Income & Other
-8.6816.8549.342.2233.24-13.41
Total Common Equity
8,5678,9338,7128,0197,9418,034
Minority Interest
124.62120.8440.1736.4335.8111.91
Shareholders' Equity
8,6919,0548,7528,0557,9778,046
Total Liabilities & Equity
11,07511,29810,4669,3979,7559,244

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
428.24290.19133.8863.47208.2379.1
Net Cash (Debt)
1,8802,8012,7142,1403,3223,217
Net Cash Growth
-30.60%3.18%26.83%-35.58%3.28%366.56%
Net Cash Per Share
1.672.492.441.923.023.01
Filing Date Shares Outstanding
1,1081,1151,1151,0911,0911,103
Total Common Shares Outstanding
1,1111,1151,1151,0911,0911,103
Working Capital
1,9882,5692,9122,4983,1083,391
Book Value Per Share
7.718.017.817.357.287.29
Tangible Book Value
6,9457,3037,3666,6906,9156,898
Tangible Book Value Per Share
6.256.556.616.136.346.26
Buildings
1,2591,2661,2221,2181,2081,218
Machinery
1,3431,3211,2581,2031,1381,109
Construction In Progress
250.26173.3262.3334.3537.694.13